Following the recent publication of a paper called “GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease“, Erwan Bézard, director of the Neurodégénérative Diseases Institute of Bordeauxpublished a commentary, that you can find here. Here’s our answer: First of all, we always pay attention to discussions and criticisms and we welcome … Read more
We recently published a paper called “GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease“. Prof Tepper briefly commented it on Twitter. Here’s our answer: Our paper is not some sort of “artefact”. Things are never so simple, they usually have an explanation. The devil, as we all know, … Read more
A new study led by Prs. Yehezkel Ben-Ari & Constance Hammond (Neurochlore and B&A Therapeutics, Marseille, France) demonstrates that bumetanide, an antagonist of the NKCC1 chloride importer, normalizes the activity of neurons in the striatum and alleviates motor impairment in a mouse model of Parkinson’s disease. These findings corroborate the results of a pilot clinical … Read more
Découvrez tous les sites de Yehezkel Ben-Ari/Discover all Yehezkel Ben-Ari websites
